GeneDx Gross Profit from 2010 to 2025

WGS Stock

104.39 7.68 7.94%

GeneDx Holdings Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit GeneDx Holdings Corp makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

2010-12-31

Previous Quarter

194.4 M

Current Value

204.1 M

Quarterly Volatility

60.8 M

Credit Downgrade

Yuan Drop

Covid

Check GeneDx Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeneDx Holdings' main balance sheet or income statement drivers, such as Interest Income of 3.1 M, Depreciation And Amortization of 30.9 M or Selling General Administrative of 142 M, as well as many indicators such as Price To Sales Ratio of 3.98, Dividend Yield of 0.0 or PTB Ratio of 8.85. GeneDx financial statements analysis is a perfect complement when working with GeneDx Holdings Valuation or Volatility modules.

Check out the analysis of GeneDx Holdings Correlation against competitors.

Latest GeneDx Holdings' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of GeneDx Holdings Corp over the last few years. Gross profit is a required income statement account that reflects total revenue of GeneDx Holdings Corp minus its cost of goods sold. It is profit before GeneDx Holdings operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. GeneDx Holdings' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeneDx Holdings' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 194.45 M

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Gross Profit

Timeline

GeneDx Gross Profit Regression Statistics

	Arithmetic Mean	77,978,741
	Geometric Mean	63,214,553
	Coefficient Of Variation	77.92
	Mean Deviation	36,327,370
	Median	82,785,000
	Standard Deviation	60,761,240
	Sample Variance	3691.9T
	Range	230.9M
	R-Value	0.11
	Mean Square Error	3908.1T
	R-Squared	0.01
	Significance	0.69
	Slope	1,399,738
	Total Sum of Squares	55378.9T

GeneDx Gross Profit History

	2025	204.1 M
	2024	194.4 M
	2023	60.6 M
	2022	-26.8 M
	2021	-16.6 M
	2020	4 M

Other Fundumenentals of GeneDx Holdings Corp

Gross Profit Margin

GeneDx Holdings Gross Profit component correlations

	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Deferred Long Term Liab	Total Current Assets	Property Plant Equipment	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Long Term Debt	Total Liab	Net Invested Capital	Short Long Term Debt	Net Working Capital	Short Term Debt	Common Stock	Long Term Debt Total	Capital Surpluse	Intangible Assets
Net Tangible Assets		-0.82	0.19	0.63	0.64	0.6	0.73	0.94	0.95	-0.92	-0.26	0.37	-0.95	0.95	0.2	0.55	-0.09	-0.47	-0.51	-0.51	-0.59
Retained Earnings	-0.82		0.01	-0.9	-0.83	-0.24	-0.95	-0.86	-0.89	0.97	-0.17	-0.61	0.92	-0.9	0.1	-0.19	0.0	0.63	0.62	0.62	0.75
Accounts Payable	0.19	0.01		0.24	0.34	0.65	0.15	0.36	0.31	-0.14	-0.67	-0.68	-0.23	0.28	0.97	0.43	0.54	0.68	0.41	0.41	0.47
Net Receivables	0.63	-0.9	0.24		0.87	0.19	0.93	0.75	0.78	-0.86	0.17	0.34	-0.8	0.78	0.11	0.04	0.31	-0.32	-0.49	-0.49	-0.56
Deferred Long Term Liab	0.64	-0.83	0.34	0.87		0.49	0.95	0.8	0.84	-0.82	-0.15	0.4	-0.84	0.84	0.19	0.41	-0.01	-0.37	-0.3	-0.3	-0.41
Total Current Assets	0.6	-0.24	0.65	0.19	0.49		0.31	0.67	0.64	-0.42	-0.91	-0.19	-0.59	0.62	0.64	0.96	-0.22	0.04	0.0	0.0	0.01
Property Plant Equipment	0.73	-0.95	0.15	0.93	0.95	0.31		0.81	0.87	-0.91	0.08	0.56	-0.88	0.88	0.02	0.23	0.04	-0.5	-0.44	-0.44	-0.57
Total Assets	0.94	-0.86	0.36	0.75	0.8	0.67	0.81		0.99	-0.95	-0.32	0.28	-0.97	0.98	0.31	0.59	0.0	-0.39	-0.44	-0.44	-0.53
Total Stockholder Equity	0.95	-0.89	0.31	0.78	0.84	0.64	0.87	0.99		-0.96	-0.28	0.37	-0.99	1.0	0.26	0.57	-0.03	-0.43	-0.44	-0.44	-0.54
Current Deferred Revenue	-0.92	0.97	-0.14	-0.86	-0.82	-0.42	-0.91	-0.95	-0.96		0.02	-0.49	0.98	-0.97	-0.08	-0.35	-0.02	0.54	0.57	0.57	0.68
Net Debt	-0.26	-0.17	-0.67	0.17	-0.15	-0.91	0.08	-0.32	-0.28	0.02		0.48	0.22	-0.25	-0.71	-0.89	0.2	-0.32	-0.22	-0.22	-0.3
Long Term Debt	0.37	-0.61	-0.68	0.34	0.4	-0.19	0.56	0.28	0.37	-0.49	0.48		-0.43	0.41	-0.74	-0.04	-0.54	-0.92	-0.45	-0.45	-0.64
Total Liab	-0.95	0.92	-0.23	-0.8	-0.84	-0.59	-0.88	-0.97	-0.99	0.98	0.22	-0.43		-1.0	-0.18	-0.53	0.07	0.5	0.53	0.53	0.62
Net Invested Capital	0.95	-0.9	0.28	0.78	0.84	0.62	0.88	0.98	1.0	-0.97	-0.25	0.41	-1.0		0.22	0.55	-0.05	-0.46	-0.46	-0.46	-0.56
Short Long Term Debt	0.2	0.1	0.97	0.11	0.19	0.64	0.02	0.31	0.26	-0.08	-0.71	-0.74	-0.18	0.22		0.44	0.54	0.74	0.44	0.44	0.52
Net Working Capital	0.55	-0.19	0.43	0.04	0.41	0.96	0.23	0.59	0.57	-0.35	-0.89	-0.04	-0.53	0.55	0.44		-0.47	-0.13	-0.07	-0.07	-0.07
Short Term Debt	-0.09	0.0	0.54	0.31	-0.01	-0.22	0.04	0.0	-0.03	-0.02	0.2	-0.54	0.07	-0.05	0.54	-0.47		0.67	0.28	0.28	0.34
Common Stock	-0.47	0.63	0.68	-0.32	-0.37	0.04	-0.5	-0.39	-0.43	0.54	-0.32	-0.92	0.5	-0.46	0.74	-0.13	0.67		0.7	0.7	0.83
Long Term Debt Total	-0.51	0.62	0.41	-0.49	-0.3	0.0	-0.44	-0.44	-0.44	0.57	-0.22	-0.45	0.53	-0.46	0.44	-0.07	0.28	0.7		1.0	0.97
Capital Surpluse	-0.51	0.62	0.41	-0.49	-0.3	0.0	-0.44	-0.44	-0.44	0.57	-0.22	-0.45	0.53	-0.46	0.44	-0.07	0.28	0.7	1.0		0.97
Intangible Assets	-0.59	0.75	0.47	-0.56	-0.41	0.01	-0.57	-0.53	-0.54	0.68	-0.3	-0.64	0.62	-0.56	0.52	-0.07	0.34	0.83	0.97	0.97

Click cells to compare fundamentals

About GeneDx Holdings Financial Statements

GeneDx Holdings shareholders use historical fundamental indicators, such as Gross Profit, to determine how well the company is positioned to perform in the future. Although GeneDx Holdings investors may analyze each financial statement separately, they are all interrelated. The changes in GeneDx Holdings' assets and liabilities, for example, are also reflected in the revenues and expenses on on GeneDx Holdings' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Gross Profit	194.4 M	204.1 M
Gross Profit Margin	0.64	0.67

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for GeneDx Stock Analysis

When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC